<< CSR 1975-2010 Home

The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 5.16

Cancer of the Cervix Uteri (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2006-2010
Females by Race
Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 16,669 98.2% 12,558 98.3% 2,331 97.7% 1,425 98.5% 115 98.3% 3,735 98.5%
Epidermoid carcinomad (8050-8131) 11,319 66.7% 8,281 64.8% 1,860 78.0% 941 65.0% 79 67.5% 2,601 68.6%
Squamous cell carcinoma (8070) 7,668 45.2% 5,535 43.3% 1,364 57.2% 610 42.2% 53 45.3% 1,577 41.6%
Squamous cell, keratinizing (8071) 1,214 7.2% 887 6.9% 200 8.4% 106 7.3% - - 330 8.7%
Squamous cell, non-keratinizing (8072) 1,525 9.0% 1,160 9.1% 197 8.3% 141 9.7% - - 445 11.7%
Squamous cell, Microinvasive (8076) 653 3.8% 508 4.0% 62 2.6% 57 3.9% - - 187 4.9%
Other (8050-8069, 8073-8075,8077-8131) 259 1.5% 191 1.5% 37 1.6% 27 1.9% - - 62 1.6%
Adenocarcinomae 4,634 27.3% 3,765 29.5% 349 14.6% 430 29.7% 27 23.1% 971 25.6%
Adenocarcinoma, NOS (8140) Adenosquamous (8560,8570) 2,456 14.5% 2,011 15.7% 178 7.5% 219 15.1% - - 515 13.6%
658 3.9% 519 4.1% 64 2.7% 63 4.4% - - 159 4.2%
Other adenocarcinomasf 1,520 9.0% 1,235 9.7% 107 4.5% 148 10.2% - - 297 7.8%
Other specific carcinomasg 235 1.4% 184 1.4% 29 1.2% 18 1.2% - - 54 1.4%
Unspecified, Carcinoma, NOS (8010-8011,8020-8022) 481 2.8% 328 2.6% 93 3.9% 36 2.5% - - 109 2.9%
Sarcomah 69 0.4% 53 0.4% - - - - - - - -
Other specific types (8720-8790,8930-8936, 8950-9030,9060-9110, 9260-9365,9380-9539) 152 0.9% 104 0.8% 29 1.2% 16 1.1% - - 23 0.6%
Unspecified (8000-8005) 88 0.5% 66 0.5% - - - - - - 17 0.4%
Total 16,978 100.0% 12,781 100.0% 2,385 100.0% 1,447 100.0% 117 100.0% 3,790 100.0%

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinomas include histologies 8141-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8571-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8175,8230-8249,8508,8510-8513,8561-8562, 8575,8580-8671.

h Sarcoma includes histologies 8680-8713,8800-8921,9040-9044,9120-9136,9150-9252,9370-9373,9540-9582.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.